These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


615 related items for PubMed ID: 20847148

  • 1. Does dual use jeopardize the potential role of smokeless tobacco in harm reduction?
    Frost-Pineda K, Appleton S, Fisher M, Fox K, Gaworski CL.
    Nicotine Tob Res; 2010 Nov; 12(11):1055-67. PubMed ID: 20847148
    [Abstract] [Full Text] [Related]

  • 2. Harm reduction policies for tobacco users.
    Gartner C, Hall W.
    Int J Drug Policy; 2010 Mar; 21(2):129-30. PubMed ID: 19944582
    [Abstract] [Full Text] [Related]

  • 3. Smokeless tobacco as a nicotine delivery device: harm or harm reduction?
    Benowitz NL.
    Clin Pharmacol Ther; 2011 Oct; 90(4):491-3. PubMed ID: 21934719
    [Abstract] [Full Text] [Related]

  • 4. Effect of smokeless tobacco product marketing and use on population harm from tobacco use policy perspective for tobacco-risk reduction.
    Kozlowski LT.
    Am J Prev Med; 2007 Dec; 33(6 Suppl):S379-86. PubMed ID: 18021913
    [Abstract] [Full Text] [Related]

  • 5. Smokeless tobacco: the epidemiology and politics of harm.
    Phillips CV, Heavner KK.
    Biomarkers; 2009 Jul; 14 Suppl 1():79-84. PubMed ID: 19604065
    [Abstract] [Full Text] [Related]

  • 6. Tobacco, nicotine and harm reduction.
    Le Houezec J, McNeill A, Britton J.
    Drug Alcohol Rev; 2011 Mar; 30(2):119-23. PubMed ID: 21375611
    [Abstract] [Full Text] [Related]

  • 7. Epidemiologic perspectives on smokeless tobacco marketing and population harm.
    Tomar SL.
    Am J Prev Med; 2007 Dec; 33(6 Suppl):S387-97. PubMed ID: 18021914
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Would alternate tobacco products use be better than smoking?
    Martinet Y, Bohadana A, Fagerström K.
    Lung Cancer; 2006 Jul; 53(1):1-4. PubMed ID: 16690160
    [Abstract] [Full Text] [Related]

  • 16. Tobacco harm reduction: conceptual structure and nomenclature for analysis and research.
    Shiffman S, Gitchell JG, Warner KE, Slade J, Henningfield JE, Pinney JM.
    Nicotine Tob Res; 2002 Jul; 4 Suppl 2():S113-29. PubMed ID: 12573173
    [Abstract] [Full Text] [Related]

  • 17. Perceived risk of harm from cigarettes or smokeless tobacco among U.S. high school seniors.
    Tomar SL, Hatsukami DK.
    Nicotine Tob Res; 2007 Nov; 9(11):1191-6. PubMed ID: 17978994
    [Abstract] [Full Text] [Related]

  • 18. Snus use in the U.S.: reducing harm or creating it?
    Twombly R.
    J Natl Cancer Inst; 2010 Oct 06; 102(19):1454-6. PubMed ID: 20870974
    [No Abstract] [Full Text] [Related]

  • 19. Trajectories of smokeless tobacco use and of cigarette smoking in a cohort of Swedish adolescents: differences and implications.
    Rosendahl KI, Galanti MR, Gilljam H.
    Nicotine Tob Res; 2008 Jun 06; 10(6):1021-7. PubMed ID: 18584465
    [Abstract] [Full Text] [Related]

  • 20. Changing smokeless tobacco products new tobacco-delivery systems.
    Hatsukami DK, Ebbert JO, Feuer RM, Stepanov I, Hecht SS.
    Am J Prev Med; 2007 Dec 06; 33(6 Suppl):S368-78. PubMed ID: 18021912
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 31.